Medical Acoustics (MA) is an early-stage company that sells a safe, hand-held disposable medical device, the Lung Flute, that uses acoustic waves to supplement the body's natural means for clearing lung secretions. The device retails for US$45 with a six month supply of replacement reeds - an important device component - which are replaced every two weeks. Replacement reed packs sell for $16.50. The product is reimbursable by Medicare. The lung flute is safer, less time consuming and more convenient than current practices and has clinical evidence and regulatory clearance for both diagnostic and therapeutic applications. The Company and its product have won awards from Frost & Sullivan ("Excellence in Technology"), Popular Science ("Best of What's New") and MD&DI ("Top 50 Companies to Watch").
Potential worldwide users of the Lung Flute include those with Chronic Obstructive Pulmonary Disease (COPD) (210M people), asthma (290M) pneumonia (429M) tuberculosis (13.9M) lung cancer and cystic fibrosis. Medical Acoustics has already established virtually 100% coverage of the US acute care market via existing distributors and will target a network of 11,000 durable medical equipment stores including major national respiratory supply chains Apira and Lincare to penetrate the home care market. MA also has 13 signed international distribution contracts.
The company has a management team of seasoned business executives and health professionals. MA has a portfolio of six global patents and 3 global trademarks. The Company has raised $3.1M to date and is seeking up to $5M of additional funding to support Home Care rollout, sales & marketing and post market clinical trials.
Helping connect you to WNY
Join us in growing the region's business success
